X0306 4 2017-04-01 0 0000827809 NOVELION THERAPEUTICS INC. NVLN 0001653133 Harshbarger Benjamin C/O NOVELION THERAPEUTICS INC. 887 GREAT NORTHERN WAY, SUITE 250 VANCOUVER A1 V5T 4T5 BRITISH COLUMBIA, CANADA 0 1 0 0 General Counsel Common Shares 2017-04-01 4 M 0 178 A 527 D Common Shares 2017-04-01 4 F 0 57 10.74 D 470 D Restricted Stock Units 2017-04-01 4 M 0 178 0.00 D Common Shares 178 177 D Reflects a one-for-five share consolidation of the common shares of the Issuer effective December 16, 2016. Each restricted stock unit represents a contingent right to receive one common share. 33.34% of the grant vested on April 1, 2016 and an additional 33.33% of the grant vested on April 1, 2017. Subject, with limited exceptions, to the Reporting Person's continued employment with the Issuer or one of its affiliates, the remainder of the grant will vest on April 1, 2018. /s/ Jennifer Fitzpatrick, attorney-in-fact 2017-04-04